Molina Healthcare (NYSE:MOH) Receives “Overweight” Rating from Cantor Fitzgerald

Cantor Fitzgerald reissued their overweight rating on shares of Molina Healthcare (NYSE:MOH) in a research note issued to investors on Thursday, Benzinga reports. Cantor Fitzgerald currently has a $406.00 target price on the stock.

Several other equities research analysts have also recently commented on MOH. Stephens reiterated an “equal weight” rating and issued a $320.00 price target on shares of Molina Healthcare in a research report on Thursday, July 25th. Wells Fargo & Company increased their target price on shares of Molina Healthcare from $315.00 to $360.00 and gave the company an “equal weight” rating in a research note on Monday, August 5th. Truist Financial cut their price objective on Molina Healthcare from $440.00 to $400.00 and set a “buy” rating for the company in a research report on Monday, July 15th. Robert W. Baird lowered their price objective on shares of Molina Healthcare from $405.00 to $331.00 and set an “outperform” rating on the stock in a research report on Thursday. Finally, TD Cowen reduced their target price on Molina Healthcare from $412.00 to $351.00 and set a “buy” rating for the company in a report on Wednesday, July 24th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Molina Healthcare currently has an average rating of “Moderate Buy” and an average price target of $367.00.

Molina Healthcare Price Performance

NYSE MOH opened at $325.54 on Thursday. Molina Healthcare has a 12 month low of $272.69 and a 12 month high of $423.92. The firm has a market capitalization of $19.08 billion, a PE ratio of 17.66, a P/E/G ratio of 0.99 and a beta of 0.58. The company’s 50 day simple moving average is $335.23 and its 200 day simple moving average is $329.39. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.57 and a quick ratio of 1.57.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, October 23rd. The company reported $6.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.96 by $0.05. Molina Healthcare had a return on equity of 28.09% and a net margin of 2.84%. The firm had revenue of $10.34 billion during the quarter, compared to analyst estimates of $9.92 billion. During the same period last year, the company posted $5.05 EPS. The firm’s quarterly revenue was up 21.0% on a year-over-year basis. As a group, equities research analysts forecast that Molina Healthcare will post 23.5 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total transaction of $339,210.00. Following the completion of the sale, the director now directly owns 18,025 shares in the company, valued at $6,114,260.25. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, CAO Maurice Hebert sold 393 shares of the company’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total value of $136,182.36. Following the completion of the sale, the chief accounting officer now directly owns 9,473 shares in the company, valued at approximately $3,282,583.96. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total value of $339,210.00. Following the transaction, the director now owns 18,025 shares in the company, valued at approximately $6,114,260.25. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.10% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in MOH. Capital International Investors boosted its position in Molina Healthcare by 0.9% during the first quarter. Capital International Investors now owns 1,665,801 shares of the company’s stock worth $684,361,000 after purchasing an additional 15,264 shares during the period. Renaissance Technologies LLC boosted its holdings in shares of Molina Healthcare by 13.3% during the 2nd quarter. Renaissance Technologies LLC now owns 949,691 shares of the company’s stock worth $282,343,000 after buying an additional 111,154 shares during the period. Boston Partners grew its stake in Molina Healthcare by 14.8% in the 1st quarter. Boston Partners now owns 798,950 shares of the company’s stock valued at $328,101,000 after buying an additional 103,245 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in Molina Healthcare by 22.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 470,932 shares of the company’s stock worth $140,026,000 after acquiring an additional 84,929 shares during the period. Finally, AQR Capital Management LLC lifted its position in Molina Healthcare by 36.2% during the 2nd quarter. AQR Capital Management LLC now owns 463,537 shares of the company’s stock worth $137,810,000 after acquiring an additional 123,121 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.